ribavirin has been researched along with Systemic Vasculitis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cacoub, P; Resche-Rigon, M; Saadoun, D; Semoun, O; Sène, D; Terrier, B | 1 |
1 other study(ies) available for ribavirin and Systemic Vasculitis
Article | Year |
---|---|
Prognostic factors in patients with hepatitis C virus infection and systemic vasculitis.
Topics: Adult; Aged; Aged, 80 and over; Antiviral Agents; Cohort Studies; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; Interferon alpha-2; Interferon-alpha; Liver Cirrhosis; Male; Middle Aged; Polyethylene Glycols; Prognosis; Prospective Studies; Recombinant Proteins; Ribavirin; Severity of Illness Index; Systemic Vasculitis; Treatment Outcome | 2011 |